Aluminum adjuvant-mediated immune system modulation

The "Immune system modulation via alum adjuvant effect" refers to the use of aluminum-based adjuvants (such as aluminum hydroxide and aluminum phosphate) to enhance vaccine-induced immune responses. These adjuvants increase the immunogenicity of co-administered antigens primarily by enhancing their uptake and presentation by antigen-presenting cells, promoting a Th2-dominated (antibody-mediated) immune response, and activating the NLRP3 inflammasome pathway and release of danger-associated molecular patterns (DAMPs) such as uric acid at the injection site. Alum adjuvants are a foundational platform in vaccine development but are not molecular targets themselves; rather, they are modulators of immunological processes[1][3][4][5][6].

Other names

Alum adjuvant effectAluminum-based adjuvant immune modulationAluminum adjuvants

Enhances immune response by forming antigen-adjuvant complexes for improved uptake by antigen-presenting cells (APCs) Sustained antigen release at injection site (depot effect) Activation of dendritic cells and macrophages Activation of inflammasomes (particularly NLRP3 in some models), leading to secretion of IL-1β, IL-18, and other cytokines Promotes Th2-biased immune response, increasing IgG1, IgE, IL-4, and IL-5 production[1][3][4][5][6]